VC-backed Pionyr names Levey as SVP and chief business officer
Pionyr Immunotherapeutics Inc, a developer of antibody therapeutics, has appointed Dr. Alicia Levey as senior vice president and chief business officer. Previously, Levey worked at Tempest Therapeutics where she was vice president and chief business officer. Pionyr's backers included OrbiMed, New Enterprise Associates, Sofinnova, SV Health Investors, Vida Ventures, Trinitas Capital, Mission Bay Capital and Osage University Partners.
27 August 2019•4 mins read
